Structure of the MLL CXXC domain–DNA complex and its functional role in MLL-AF9 leukemia

被引：0
|
作者：
Tomasz Cierpicki
Laurie E Risner
Jolanta Grembecka
Stephen M Lukasik
Relja Popovic
Monika Omonkowska
David D Shultis
Nancy J Zeleznik-Le
John H Bushweller
机构：
[1] University of Virginia,Department of Molecular Physiology and Biological Physics
[2] Molecular Biology Program,Department of Medicine
[3] Oncology Institute,Department of Chemistry
[4] Loyola University,undefined
[5] University of Virginia,undefined
[6] These authors contributed equally to this work. Present address: Department of Pathology,undefined
[7] University of Michigan,undefined
[8] Ann Arbor,undefined
[9] Michigan,undefined
[10] USA (T.C. and J.G.).,undefined
来源：
Nature Structural & Molecular Biology | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
MLL fusions are linked to leukemias and retain the CXXC domain, which binds unmethylated DNA. The NMR structure of CXXC–DNA now indicates the interactions underlying binding. Mutation of a key residue to a nonbinding form decreases proliferation caused by an MLL-AF9 fusion and leukemias induced by MLL-AF9 expression in mice.
引用
收藏
页码：62 / 68
页数：6
相关论文
共 50 条
  • [31] Role of AF4 and Dot1 in MLL-AF9 mediated leukemogenesis
    Lumba, Bhavna
    Hemenway, Charles S.
    CANCER RESEARCH, 2011, 71
  • [32] MLL-AF9 leukemia stem cells: Hardwired or taking cues from the microenvironment?
    Muntean, Andrew G.
    Hess, Jay L.
    CANCER CELL, 2008, 13 (06) : 465 - 467
  • [33] Clonal Evolution of Leukemia With MLL-AF9 from Myeloid to T-Lineage
    Tomoda, Takahiro
    Nishimura, Akira
    Ono, Rintaro
    Isoda, Takeshi
    Inoue, Maiko
    Kamiya, Takahiro
    Yanagimachi, Masakatsu
    Imai, Kohsuke
    Kanegane, Hirokazu
    Hasegawa, Daisuke
    Morio, Tomohiro
    Manabe, Atsushi
    Takagi, Masatoshi
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S111 - S111
  • [34] Heterogeneous effects of M-CSF isoforms on the progression of MLL-AF9 leukemia
    Wang, Rong
    Feng, Wenli
    Yang, Feifei
    Yang, Xiao
    Wang, Lina
    Chen, Chong
    Hu, Yuting
    Ren, Qian
    Zheng, Guoguang
    IMMUNOLOGY AND CELL BIOLOGY, 2018, 96 (02): : 190 - 203
  • [35] A CASE OF MLL-AF9 REARRANGED ACUTE MONOCYTIC LEUKEMIA WITH MARKED BILATERAL NEPHROMEGALY
    Mitani, Kazuki
    Fujino, Hisanori
    Okada, Hidenori
    Shiraishi, Kei
    Harada, Taro
    Obu, Satoshi
    Nomura, Anryu
    Sumimoto, Shinichi
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [36] Loss of Dnmt3b accelerates MLL-AF9 leukemia progression
    Y Zheng
    H Zhang
    Y Wang
    X Li
    P Lu
    F Dong
    Y Pang
    S Ma
    H Cheng
    S Hao
    F Tang
    W Yuan
    X Zhang
    T Cheng
    Leukemia, 2016, 30 : 2373 - 2384
  • [37] New Therapeutic Targets For MLL plus AML Identified via Mll-AF9 Depletion
    Fleischmann, K. K.
    Pagel, P.
    Schmid, I.
    Roscher, A. A.
    ANNALS OF HEMATOLOGY, 2015, 94 : S86 - S86
  • [38] MLL-AF9 rearrangement in myeloid sarcomas involving the breast
    Boting Wu
    Feng Li
    Shanhua Zou
    Annals of Hematology, 2014, 93 : 709 - 710
  • [39] IDENTIFYING THE CELL OF ORIGIN IN MLL-AF9 INFANT LEUKAEMIA
    Antunes, Eric
    Ottersbach, Katrin
    Schwaller, Juerg
    EXPERIMENTAL HEMATOLOGY, 2020, 88 : S54 - S54
  • [40] The mechanism of MYB transcriptional regulation by MLL-AF9 oncoprotein
    Cao, Lu
    Mitra, Partha
    Gonda, Thomas J.
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345